NASDAQ:EGRX
$20.45
(
0.442%
)
Friday, 26th May 2023
Eagle Pharmaceuticals Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $18.93 | $30.40 | Friday, 26th May 2023 EGRX stock ended at $20.45. This is 0.442% more than the trading day before Thursday, 25th May 2023. During the day the stock fluctuated 3.26% from a day low at $20.25 to a day high of $20.91. |
| 90 days | $18.93 | $32.44 | |
| 52 weeks | $18.93 | $49.00 |
Historical Eagle Pharmaceuticals prices
| Date | Open | High | Low | Close | Volume |
| 2023-05-26 | $20.38 | $20.91 | $20.25 | $20.45 | 93 475 |
| 2023-05-25 | $20.90 | $20.90 | $20.22 | $20.36 | 144 905 |
| 2023-05-24 | $20.91 | $21.02 | $20.55 | $20.92 | 89 847 |
| 2023-05-23 | $21.23 | $21.74 | $20.96 | $20.99 | 77 872 |
| 2023-05-22 | $21.27 | $21.41 | $20.73 | $21.32 | 80 789 |
| 2023-05-19 | $20.83 | $21.59 | $20.82 | $21.23 | 127 585 |
| 2023-05-18 | $20.14 | $20.66 | $20.12 | $20.50 | 132 471 |
| 2023-05-17 | $19.98 | $20.35 | $19.43 | $20.15 | 134 369 |
| 2023-05-16 | $20.75 | $20.75 | $19.72 | $19.94 | 162 239 |
| 2023-05-15 | $20.70 | $21.60 | $20.48 | $21.03 | 221 653 |
| 2023-05-12 | $20.94 | $21.04 | $18.93 | $20.59 | 221 973 |
| 2023-05-11 | $21.14 | $21.29 | $20.33 | $20.96 | 171 787 |
| 2023-05-10 | $25.29 | $25.29 | $20.03 | $21.11 | 227 441 |
| 2023-05-09 | $30.40 | $30.40 | $25.23 | $25.29 | 168 858 |
| 2023-05-08 | $28.89 | $29.40 | $28.58 | $29.17 | 76 347 |
| 2023-05-05 | $28.80 | $28.91 | $28.47 | $28.65 | 68 058 |
| 2023-05-04 | $28.23 | $28.47 | $27.90 | $28.37 | 50 904 |
| 2023-05-03 | $28.31 | $28.99 | $28.14 | $28.38 | 59 725 |
| 2023-05-02 | $28.04 | $28.59 | $27.43 | $28.19 | 150 672 |
| 2023-05-01 | $28.02 | $28.68 | $28.02 | $28.11 | 96 864 |
| 2023-04-28 | $27.86 | $28.56 | $27.86 | $28.08 | 67 858 |
| 2023-04-27 | $27.73 | $28.30 | $27.47 | $27.94 | 58 764 |
| 2023-04-26 | $27.40 | $27.79 | $27.33 | $27.69 | 86 685 |
| 2023-04-25 | $27.53 | $27.71 | $27.26 | $27.54 | 65 230 |
| 2023-04-24 | $27.62 | $27.90 | $27.31 | $27.70 | 57 844 |
| 2023-04-21 | $27.83 | $28.10 | $27.59 | $27.62 | 72 884 |
| 2023-04-20 | $28.05 | $28.15 | $27.39 | $27.85 | 68 672 |
| 2023-04-19 | $27.86 | $28.82 | $27.74 | $28.40 | 67 765 |
| 2023-04-18 | $28.97 | $28.97 | $27.69 | $27.81 | 113 573 |
| 2023-04-17 | $30.01 | $30.43 | $28.77 | $28.87 | 90 524 |
| 2023-04-14 | $30.75 | $30.83 | $29.59 | $29.71 | 114 861 |
| 2023-04-13 | $30.51 | $31.40 | $30.51 | $30.75 | 60 189 |
| 2023-04-12 | $31.49 | $31.49 | $30.26 | $30.30 | 82 298 |
| 2023-04-11 | $31.02 | $31.85 | $31.02 | $31.37 | 61 440 |
| 2023-04-10 | $31.58 | $31.75 | $30.56 | $30.99 | 146 568 |
| 2023-04-06 | $31.35 | $32.44 | $31.12 | $31.87 | 209 036 |
| 2023-04-05 | $29.62 | $31.27 | $29.30 | $31.24 | 183 574 |
| 2023-04-04 | $29.65 | $29.90 | $29.18 | $29.85 | 180 126 |
| 2023-04-03 | $28.39 | $29.82 | $28.39 | $29.65 | 293 428 |
| 2023-03-31 | $28.14 | $28.83 | $27.12 | $28.37 | 211 268 |
| 2023-03-30 | $28.64 | $28.94 | $27.43 | $27.88 | 149 238 |
| 2023-03-29 | $28.30 | $28.99 | $28.25 | $28.53 | 134 246 |
| 2023-03-28 | $27.67 | $28.44 | $27.49 | $28.17 | 159 235 |
| 2023-03-27 | $26.81 | $27.72 | $26.58 | $27.67 | 179 022 |
| 2023-03-24 | $25.62 | $26.72 | $25.40 | $26.58 | 147 030 |
| 2023-03-23 | $26.18 | $26.91 | $25.55 | $25.67 | 169 008 |
| 2023-03-22 | $26.89 | $27.45 | $26.02 | $26.05 | 208 653 |
| 2023-03-21 | $26.99 | $27.50 | $26.51 | $26.93 | 179 696 |
| 2023-03-20 | $25.84 | $26.88 | $25.48 | $26.69 | 298 480 |
| 2023-03-17 | $26.11 | $26.50 | $25.41 | $25.70 | 1 271 999 |
About Eagle Pharmaceuticals
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. Its product candidates also include EP-4104, a dantrolene sodium ... EGRX Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
